Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phair

Showing results (441-450 of 499) with videos related to

Pageof 50
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2002
Modulating influence on HIV/AIDS by interacting RANTES gene variantsPing An, George W Nelson, Lihua Wang, et al.
The New England Journal of Medicine|August 17, 1995
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials GroupP A Volberding, S W Lagakos, J M Grimes, et al.
Stroke|August 28, 2010
Association between human immunodeficiency virus infection and stiffness of the common carotid arteryEric C Seaberg, Lorie Benning, A Richey Sharrett, et al.
Nature Medicine|August 1, 1996
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaS J Gao, L Kingsley, M Li, et al.
AIDS Research and Human Retroviruses|March 11, 1990
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.
JAMA|August 10, 1994
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials GroupP A Volberding, S W Lagakos, J M Grimes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2008
Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survivalSher L Hendrickson, Lisa P Jacobson, George W Nelson, et al.
Journal of Virology|October 10, 1998
Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1L Zhang, T He, Y Huang, et al.
STAR Protocols|September 27, 2022
DIA label-free proteomic analysis of murine bone-marrow-derived macrophagesChrista P Baker, Iain R Phair, Alejandro J Brenes, et al.
European Journal of Pharmacology|March 9, 2026
Colchicine acutely reduces liver-secreted inflammatory and metabolic proteins in bloodMagdalena Sovakova, Iain R Phair, Erika Gutierrez-Lara, et al.
Pageof 50

Showing results (441-450 of 499) with videos related to

Sort By:
Pageof 50
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2002
Modulating influence on HIV/AIDS by interacting RANTES gene variantsPing An, George W Nelson, Lihua Wang, et al.
The New England Journal of Medicine|August 17, 1995
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials GroupP A Volberding, S W Lagakos, J M Grimes, et al.
Stroke|August 28, 2010
Association between human immunodeficiency virus infection and stiffness of the common carotid arteryEric C Seaberg, Lorie Benning, A Richey Sharrett, et al.
Nature Medicine|August 1, 1996
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaS J Gao, L Kingsley, M Li, et al.
AIDS Research and Human Retroviruses|March 11, 1990
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.
JAMA|August 10, 1994
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials GroupP A Volberding, S W Lagakos, J M Grimes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2008
Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survivalSher L Hendrickson, Lisa P Jacobson, George W Nelson, et al.
Journal of Virology|October 10, 1998
Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1L Zhang, T He, Y Huang, et al.
STAR Protocols|September 27, 2022
DIA label-free proteomic analysis of murine bone-marrow-derived macrophagesChrista P Baker, Iain R Phair, Alejandro J Brenes, et al.
European Journal of Pharmacology|March 9, 2026
Colchicine acutely reduces liver-secreted inflammatory and metabolic proteins in bloodMagdalena Sovakova, Iain R Phair, Erika Gutierrez-Lara, et al.
Pageof 50